COLOMBATTI, RAFFAELLA
 Distribuzione geografica
Continente #
NA - Nord America 5.291
AS - Asia 2.771
EU - Europa 1.729
AF - Africa 857
SA - Sud America 712
OC - Oceania 82
Continente sconosciuto - Info sul continente non disponibili 44
Totale 11.486
Nazione #
US - Stati Uniti d'America 4.852
SG - Singapore 1.022
BR - Brasile 442
HK - Hong Kong 430
CN - Cina 308
IT - Italia 229
DE - Germania 184
VN - Vietnam 175
PL - Polonia 142
FI - Finlandia 125
FR - Francia 97
SE - Svezia 79
RU - Federazione Russa 65
NL - Olanda 60
GB - Regno Unito 58
AT - Austria 56
IN - India 47
TR - Turchia 44
CI - Costa d'Avorio 43
AR - Argentina 42
ZA - Sudafrica 40
BJ - Benin 38
IL - Israele 38
PY - Paraguay 38
IQ - Iraq 36
MX - Messico 36
UA - Ucraina 36
GH - Ghana 34
MA - Marocco 34
PE - Perù 34
CA - Canada 32
IR - Iran 32
KG - Kirghizistan 32
AL - Albania 30
ES - Italia 30
AO - Angola 29
BB - Barbados 29
ID - Indonesia 29
LC - Santa Lucia 29
RO - Romania 29
UZ - Uzbekistan 29
CO - Colombia 28
DJ - Gibuti 28
EC - Ecuador 28
IE - Irlanda 28
ML - Mali 28
EG - Egitto 27
LB - Libano 27
CM - Camerun 26
GA - Gabon 26
JP - Giappone 26
LY - Libia 26
PT - Portogallo 26
RS - Serbia 26
BE - Belgio 25
CW - ???statistics.table.value.countryCode.CW??? 25
GT - Guatemala 25
KH - Cambogia 25
MD - Moldavia 25
MK - Macedonia 25
NP - Nepal 25
PA - Panama 25
SK - Slovacchia (Repubblica Slovacca) 25
VE - Venezuela 25
CR - Costa Rica 24
HN - Honduras 24
JO - Giordania 24
KR - Corea 24
NO - Norvegia 24
TN - Tunisia 24
AE - Emirati Arabi Uniti 23
KZ - Kazakistan 23
MN - Mongolia 23
MZ - Mozambico 23
PK - Pakistan 23
PS - Palestinian Territory 23
TJ - Tagikistan 23
BG - Bulgaria 22
CU - Cuba 22
DK - Danimarca 22
GR - Grecia 22
NC - Nuova Caledonia 22
NG - Nigeria 22
NI - Nicaragua 22
SN - Senegal 22
UY - Uruguay 22
AZ - Azerbaigian 21
BZ - Belize 21
CY - Cipro 21
CZ - Repubblica Ceca 21
HU - Ungheria 21
LA - Repubblica Popolare Democratica del Laos 21
ME - Montenegro 21
CH - Svizzera 20
DO - Repubblica Dominicana 20
EE - Estonia 20
HR - Croazia 20
KE - Kenya 20
MY - Malesia 20
PH - Filippine 20
Totale 10.584
Città #
Fairfield 740
Singapore 564
Ashburn 525
Woodbridge 459
Hong Kong 413
Houston 355
Chandler 334
Seattle 276
Cambridge 250
Wilmington 238
Ann Arbor 176
Beijing 147
Boardman 123
Bytom 111
Santa Clara 93
Princeton 85
Munich 69
Medford 67
San Diego 66
Jacksonville 64
Padova 57
Helsinki 49
Des Moines 46
Ho Chi Minh City 45
Los Angeles 45
Abidjan 43
Hanoi 41
Roxbury 37
Vienna 37
Cotonou 36
Dong Ket 36
Milan 35
São Paulo 33
Nuremberg 31
Bishkek 30
Chicago 30
Castries 29
Hefei 29
Bamako 28
New York 28
Turku 28
Djibouti 27
Bridgetown 26
Buffalo 26
Libreville 26
Tashkent 26
Accra 25
Panama City 24
Amman 23
London 23
Luanda 23
Phnom Penh 23
Dakar 22
Dublin 22
Dushanbe 22
Lima 22
Managua 22
Ulan Bator 22
Havana 21
Willemstad 21
Baku 20
Montevideo 20
Redondo Beach 20
San José 20
Vientiane 20
Harare 19
Kampala 19
Noumea 19
Riga 19
Cairo 18
Guatemala City 18
Nanjing 18
Maputo 17
Nairobi 17
Reykjavik 17
Tirana 17
Chisinau 16
Nouakchott 16
Podgorica 16
Rio de Janeiro 16
Tripoli 16
Brussels 15
Casablanca 15
Frankfurt am Main 15
Kingstown 15
Antananarivo 14
Cayenne 14
Dar es Salaam 14
Kinshasa 14
Lappeenranta 14
Nassau 14
Niamey 14
Tallinn 14
Andorra la Vella 13
Belgrade 13
Brooklyn 13
Dili 13
Istanbul 13
Johannesburg 13
Ouagadougou 13
Totale 7.015
Nome #
Coagulation Activation in Children with Sickle Cell Disease Is Associated with Cerebral Small Vessel Vasculopathy 220
Spleen histology in children with sickle cell disease and hereditary spherocytosis: Hints on the disease pathophysiology 220
Evaluation of Technical Issues in a Pilot Multicenter Newborn Screening Program for Sickle Cell Disease 192
Treosulfan-based conditioning regimen in sibling and alternative donor hematopoietic stem cell transplantation for children with sickle cell disease 191
Pulmonary hypertension in sickle cell disease children under 10 years of age 189
Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action 186
Haploidentical stem cell transplantation cures autoimmune hepatitis and cerebrovascular disease in a patient with sickle cell disease 180
primary stroke prevention for sickle cell disease in north-east Italy: the role of ethnic issues in establishing a Transcranial Doppler screening program 176
Malaria prevention reduces in-hospital mortality among severely ill tuberculosis patients: a three-step intervention in Bissau, Guinea-Bissau. 173
Cognitive evoked potentials and neural networks are abnormal in children with sickle cell disease and not related to the degree of anaemia, pain and silent infarcts 170
Tricuspid regurgitant velocity elevation in a three-year old child with sickle cell anemia and recurrent acute chest syndromes reversed not by hydroxyurea but by bone marrow transplantation 168
Airways obstruction and pulmonary capillary blood volume in children with sickle cell disease 166
Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference 164
Hospitalization of children with sickle cell disease in a region with increasing immigration rates. 163
A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis 162
European Intergroup Studies (MMT4-89 and MMT4-91) on Childhood Metastatic Rhabdomyosarcoma: Final Results and Analysis of Prognostic Factors 158
Transcranial Doppler Sonography in children with sickle cell disease and silent ischemic lesions 157
An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research 148
Selective Difficulties in Lexical Retrieval and Nonverbal Executive Functioning in Children With HbSS Sickle Cell Disease 147
Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey 146
Comprehensive care for sickle cell disease immigrant patients: A reproducible model achieving high adherence to minimum standards of care. 144
Intellectual impairment and TCD evaluation in children with sickle cell disease and silent stroke 143
Acute Chest Syndrome in Children with Sickle Cell Disease in Italy: Results of a National Survey from the Italian Association of Pediatric Hematology Oncology (AIEOP) 139
Early-onset indicators of a hypercoagulable state and clinical complications in a cohort of children with sickle cell trait 135
Childhood sickle cell disease in north-east Italy: genetic, hematologic, clinical characteristics and social challenges of an emerging disease: a single center experience 129
Longitudinal evaluation of cerebral white matter hyperintensities lesion volume in children with sickle cell disease 128
Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes 128
High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma 128
Intellectual function evaluation of first generation immigrant children with sickle cell disease: the role of language and sociodemographic factors 126
A multinational trial of prasugrel for sickle cell vaso-occlusive events 125
Microvasculopathy and biomarkers in sickle cell disease: the promise of non-invasive real-time in vivo tools 121
Association between a combination of single nucleotide polymorphisms and large vessel cerebral vasculopathy in African children with sickle cell disease 121
Distribution of HbS Allele and Haplotypes in a Multi-Ethnic Population of Guinea Bissau, West Africa: Implications for Public Health Screening 121
INTENSIVE CHEMOTHERAPY FOR CHILDREN AND YOUNG ADULTS WITH METASTATIC NEUROECTODERMAL TUMORS OF THE SOFT TISSUE 117
Anemia and transfusion in the neonate 116
An Educational Study Promoting the Delivery of Transcranial Doppler Ultrasound Screening in Paediatric Sickle Cell Disease: A European Multi-Centre Perspective 113
Cognition and the default mode network in children with sickle cell disease: A resting state functional MRI study 113
null 109
Pediatric Moyamoya Disease and Syndrome in Italy: A Multicenter Cohort 106
A short-term intervention for the treatment of severe malnutrition in a post-conflict country: Results of a survey in Guinea Bissau 105
CK2β Regulates Hematopoietic Stem Cell Biology and Erythropoiesis 104
Monitoring oral iron therapy in children with iron deficiency anemia: an observational, prospective, multicenter study of AIEOP patients (Associazione Italiana Emato-Oncologia Pediatrica) 104
Organizing national responses for rare blood disorders: The Italian experience with sickle cell disease in childhood 104
Prevention of neurovascular complications in children with Sickle Cell Disease in the real-world setting: What adult medicine physicians should know 102
Limited access to transcranial Doppler screening and stroke prevention for children with sickle cell disease in Europe: Results of a multinational EuroBloodNet survey 101
Relationship between hemoglobin, hemolysis, and transcranial Doppler velocities in children with sickle cell disease: Results from a long-term natural history study in Italy in the era of multimodal therapy 101
ENERCA clinical recommendations for disease management and prevention of complications of sickle cell disease in children 101
Lessons learned from the H1N1 pandemic: The need to improve systematic vaccination in Sickle Cell Disease children. A multi center survey in Italy 101
Newborn screening for sickle cell disease in Europe 101
Feasibility and effectiveness of tuberculosis active case-finding among children living with tuberculosis relatives: A cross-sectional study in Guinea-Bissau 100
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience 100
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission 98
Are we ready for new strategies to prevent stroke in children with sickle cell disease? 97
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trial 97
The Management of Sickle Cell Pain in the Emergency Department: A Priority For Health Systems. 97
Direct detection by the xpert MTB/RIF assay and characterization of multi and poly drug- resistant tuberculosis in Guinea-Bissau, West Africa 97
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort 97
THE ROLE OF EXECUTIVE DYSFUNCTIONS IN THE VERBAL LANGUAGE DEFICITS OF CHILDREN WITH SICKLE CELL DISEASE 95
Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: a retrospective cohort study of A.I.E.O.P. patients (Associazione Italiana Emato-Oncologia Pediatrica) 95
Severe hemolytic anemia in a newborn: Look out for rare Gardos channelopathies due to KCNN4 mutation 94
Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY) 94
HbS/β+ thalassemia: Really a mild disease? A National survey from the AIEOP Sickle Cell Disease Study Group with genotype-phenotype correlation 93
The Guinea-Bissau Family of Mycobacterium tuberculosis Complex Revisited 91
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort 91
Novel findings from the multinational DOVE study on geographic and age-related differences in pain perception and analgesic usage in children with sickle cell anaemia 90
Thrombocytopenia and splenomegaly: An unusual presentation of congenital hepatic fibrosis 90
Annual Academy of Sickle Cell and Thalassaemia (ASCAT) conference: a summary of the proceedings 88
Hematological characteristics and hepatobiliary complications of hereditary spherocytosis in a tertiary care pediatric center: optimizing diagnosis and care through local and international networks 87
Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned 86
Editorial for special issue “newborn screening for sickle cell disease and other haemoglobinopathies” 86
Residual Cerebrovascular Morbidity Despite Treatment in Pediatric Sickle Cell Disease Highlights Opportunities for Earlier, Intensified Monitoring and Treatment 84
Short term advantages of a public-private partnership for tuberculosis in Guinea Bissau: Reduction of mortality and increased diagnostic capacity 84
Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study 83
Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet 80
American Society of Hematology 2020 Podcast Collection: Sickle Cell Anaemia 80
Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective 79
Point-of-care testing allows successful simultaneous screening of sickle cell disease, HIV, and tuberculosis for households in rural Guinea-Bissau, West Africa 79
Successful Treatment of Severe Iatrogenic Calcinosis Cutis with Intravenous Sodium Thiosulfate in a Child Affected by T-Acute Lymphoblastic Leukemia 78
Paediatric Emergency Department use and risk factors for admission in Sickle Cell Disease Children in a country without comprehensive care 78
Sickle cell disease: embedding patient participation into an international conference can transform the role of lived experience 77
Intracranial circulation in sickle cell disease 77
Treatment of dental and orthodontic complications in thalassaemia 77
Early splenectomy in sickle cell disease: another piece of the puzzle 76
Dalla Guinea Bissau a Padova per l’alta specializzazione:un nuovo modello per la globalozzazione della Pediatria? 76
Disease burden and quality of life of in children with sickle cell disease in Italy: time to be considered a priority 75
Problematiche acute dell’Anemia Falciforme nel bambino: esperienza del Pronto Soccorso Pediatrico di Padova 73
Complicanze acute dell’anemia falciforme nel bambino: progressi nell’ottimizzazione delle cure ed aree suscettibili di miglioramento nell’esperienza del Pronto Soccorso Pediatrico di Padova 73
Acute chest syndrome in children with sickle cell disease: Data from a national AIEOP cohort identify priority areas of intervention in a hub-and-spoke system 72
Contamination of drinking water sources during the rainy season in an urban post-conflict community in Guinea Bissau: implications for sanitation priority 71
Posterior cerebral circulation in children with sickle cell anemia: an uncharted territory 69
European migration crises: The role of national hemoglobinopathy registries in improving patient access to care 68
Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy 67
Visual cortex changes in children with sickle cell disease and normal visual acuity: a multimodal magnetic resonance imaging study 66
Environmental Factors in Northern Italy and Sickle Cell Disease Acute Complications: A Multicentric Study 66
Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapy 66
The impact of Parvovirus B19 on hereditary haemolytic anaemias 66
Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and Ghana 66
Crisi dolorose articolari in bambini di colore: il sospetto di anemia falciforme nel Pronto Soccorso pediatrico di un’area non endemica 65
Real-Life experience with hydroxyurea in patients with sickle cell disease: Results from the prospective ESCORT-HU cohort study 65
Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato‐Oncologia Pediatrica) study group 64
Totale 11.025
Categoria #
all - tutte 39.123
article - articoli 38.803
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.926


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021940 0 0 0 0 10 176 135 120 174 146 60 119
2021/2022942 22 37 102 63 79 81 25 149 69 29 77 209
2022/2023663 177 73 13 73 83 56 5 48 74 2 54 5
2023/2024438 20 54 47 32 25 43 25 37 21 13 47 74
2024/20252.248 7 178 103 68 253 36 79 192 254 98 406 574
2025/20264.760 496 788 1.528 1.666 282 0 0 0 0 0 0 0
Totale 11.602